A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 16047335)

Published in Cancer on September 01, 2005

Authors

Carmen R Isasi1, Ping Lu, M Donald Blaufox

Author Affiliations

1: Department of Nuclear Medicine, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York 10025, USA. crisasi@aecom.yu.edu

Articles citing this

The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients. Eur J Nucl Med Mol Imaging (2012) 1.55

Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev (2008) 1.16

Current role of FDG PET/CT in lymphoma. Eur J Nucl Med Mol Imaging (2014) 1.06

Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT. Cancer Imaging (2010) 0.96

Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis. Oncologist (2010) 0.91

Unifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials. Eur J Nucl Med Mol Imaging (2010) 0.86

Current status of PET/CT in the diagnosis and follow up of lymphomas. Rev Bras Hematol Hemoter (2011) 0.84

Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions. Ann Nucl Med (2012) 0.83

Testicular fluorine-18 fludeoxyglucose uptake on positron emission tomography CT in patients with lymphoma: clinical significance and management impact. Br J Radiol (2014) 0.82

Hodgkin lymphoma, version 2.2015. J Natl Compr Canc Netw (2015) 0.82

State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response". Front Oncol (2013) 0.81

The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease. Blood (2014) 0.79

Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT. Eur J Nucl Med Mol Imaging (2014) 0.78

The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD). BMC Cancer (2016) 0.77

The evolving role of F-FDG PET scans in patients with aggressive non-Hodgkin's lymphoma. European J Clin Med Oncol (2010) 0.77

Newer Diagnostic Methods in Oncology. Med J Armed Forces India (2011) 0.75

Cellular density evaluation for malignant lymphoma using equivalent cross-relaxation rate imaging - initial experience. Korean J Radiol (2010) 0.75

Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/Cotswolds Meeting Criteria. Asia Ocean J Nucl Med Biol (2015) 0.75

Low-Dose PET/CT and Full-Dose Contrast-Enhanced CT at the Initial Staging of Localized Diffuse Large B-Cell Lymphomas. Clin Med Insights Blood Disord (2016) 0.75

The evolving role of response-adapted PET imaging in Hodgkin lymphoma. Ther Adv Hematol (2016) 0.75

The role of FDG-PET in Hodgkin lymphoma. Contemp Oncol (Pozn) (2017) 0.75

Evolution of lymphoma staging and response evaluation: current limitations and future directions. Nat Rev Clin Oncol (2017) 0.75

Articles by these authors

Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science (2002) 2.45

Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med (2003) 2.33

Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest (2007) 1.79

A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope. Proc Natl Acad Sci U S A (2005) 1.74

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology (2010) 1.66

Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters. Proc Natl Acad Sci U S A (2013) 1.60

A haplotype map of genomic variations and genome-wide association studies of agronomic traits in foxtail millet (Setaria italica). Nat Genet (2013) 1.58

5-(Methoxy-carbon-yl)thio-phene-2-carboxylic acid. Acta Crystallogr Sect E Struct Rep Online (2009) 1.57

Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences. Drug Metab Dispos (2011) 1.54

Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes. Proc Natl Acad Sci U S A (2013) 1.54

Lack of a pharmacokinetic effect of raltegravir on midazolam: in vitro/in vivo correlation. J Clin Pharmacol (2007) 1.51

Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1. Biochem J (2013) 1.45

Nitric oxide synthase inhibition abolishes exercise-mediated protection against isoproterenol-induced cardiac hypertrophy in female mice. Cardiology (2015) 1.38

Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivatives. Bioorg Med Chem (2007) 1.35

Phacoemulsification induced transient swelling of corneal Descemet's Endothelium Complex imaged with ultra-high resolution optical coherence tomography. PLoS One (2013) 1.26

Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitant. Drug Metab Dispos (2004) 1.24

Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer. PLoS One (2012) 1.22

Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells. Breast Cancer Res (2014) 1.19

A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat (2005) 1.19

Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia. Proc Natl Acad Sci U S A (2013) 1.17

Nuclear medicine studies of the prostate, testes, and bladder. Semin Nucl Med (2006) 1.17

In situ observation of graphene sublimation and multi-layer edge reconstructions. Proc Natl Acad Sci U S A (2009) 1.15

Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann Surg (2011) 1.10

Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer. Breast Cancer Res (2003) 1.10

Clinical implications for nestin protein expression in breast cancer. Cancer Sci (2009) 1.10

Vertical and horizontal thickness profiles of the corneal epithelium and Bowman's layer after orthokeratology. Invest Ophthalmol Vis Sci (2013) 1.10

Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma. Hepatology (2014) 1.09

2-(Tritylsulfan-yl)ethyl 2-iodo-benzoate. Acta Crystallogr Sect E Struct Rep Online (2011) 1.08

Assessment of genetic diversity in broomcorn millet (Panicum miliaceum L.) using SSR markers. J Genet Genomics (2009) 1.07

Girdin protein: a new potential distant metastasis predictor of breast cancer. Med Oncol (2011) 1.07

Ultrahigh thermoelectric performance by electron and phonon critical scattering in Cu2 Se1-x Ix. Adv Mater (2013) 1.07

BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma. Cancer Res (2012) 1.07

Impact of pH on plasma protein binding in equilibrium dialysis. Mol Pharm (2008) 1.05

Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases. Surg Oncol (2008) 1.04

Buckyballs meet viral nanoparticles: candidates for biomedicine. J Am Chem Soc (2009) 1.04

Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo. J Biol Chem (2010) 1.04

Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies. Blood (2005) 1.04

Genetic diversity and population structure of Chinese foxtail millet [Setaria italica (L.) Beauv.] landraces. G3 (Bethesda) (2012) 1.04

Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer (2007) 1.03

Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes. Am J Clin Oncol (2013) 1.03

Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma. Int J Cancer (2011) 1.01

Massive sorghum collection genotyped with SSR markers to enhance use of global genetic resources. PLoS One (2013) 1.01

Fiber bragg gratings made with a phase mask and 800-nm femtosecond radiation. Opt Lett (2003) 1.00

Transcriptome profiling and digital gene expression by deep-sequencing in normal/regenerative tissues of planarian Dugesia japonica. Genomics (2011) 1.00

Mohawk promotes the tenogenesis of mesenchymal stem cells through activation of the TGFβ signaling pathway. Stem Cells (2015) 1.00

Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes. Mol Carcinog (2007) 0.99

The role of the slug transcription factor in cell migration during corneal re-epithelialization in the dog. Exp Eye Res (2006) 0.98

Third generation solid dispersions of ferulic acid in electrospun composite nanofibers. Int J Pharm (2010) 0.98

Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor. Cancer Res (2011) 0.97

Distribution of solitary lymph nodes in primary gastric cancer: a retrospective study and clinical implications. World J Gastroenterol (2007) 0.96

Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. Int J Cancer (2012) 0.96

Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse. J Clin Invest (2013) 0.96

Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose. Cancer Res (2005) 0.95

Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease. Proc Natl Acad Sci U S A (2014) 0.94

Bottlenecks in the expression and secretion of heterologous proteins in Bacillus subtilis. Res Microbiol (2004) 0.94

RNA editing sites exist in protein-coding genes in the chloroplast genome of Cycas taitungensis. J Integr Plant Biol (2011) 0.94

IgG2m4, an engineered antibody isotype with reduced Fc function. MAbs (2010) 0.93

Hepatitis B virus genotype-associated variability in antiviral response to adefovir dipivoxil therapy in Chinese Han population. Tohoku J Exp Med (2008) 0.93

Isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/m cell cycle arrest and apoptosis. PLoS One (2012) 0.93

FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging (2005) 0.93

Predictive factors of lymph node metastasis in undifferentiated early gastric cancers and application of endoscopic mucosal resection. Surg Oncol (2010) 0.93

Crucial transcription factors in tendon development and differentiation: their potential for tendon regeneration. Cell Tissue Res (2014) 0.92

LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. J Pharmacol Exp Ther (2012) 0.92

Tumor biology-guided radiotherapy treatment planning: gross tumor volume versus functional tumor volume. Semin Nucl Med (2008) 0.92

Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway. Oncol Lett (2012) 0.91

Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells. Mol Pharm (2009) 0.91

Changing the behavior of chromophores from aggregation-caused quenching to aggregation-induced emission: development of highly efficient light emitters in the solid state. Adv Mater (2010) 0.91

Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2. Free Radic Biol Med (2007) 0.90

Co-expression of Oct-4 and Nestin in human breast cancers. Mol Biol Rep (2011) 0.90

Characterization and localization of a human serine racemase. Brain Res Mol Brain Res (2004) 0.90

Fluorescent conjugated dendrimers with fluorinated terminal groups: nanofiber formation and electroluminescence properties. Org Lett (2008) 0.90

Survival trends in gastric cancer patients of Northeast China. World J Gastroenterol (2011) 0.90

Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity. Eur J Pharmacol (2009) 0.90

International Scientific Committee of Radionuclides in Nephrourology (ISCORN) consensus on renal transit time measurements. Semin Nucl Med (2008) 0.90

Predictive factors for lymph node metastasis in poorly differentiated early gastric cancer and their impact on the surgical strategy. World J Gastroenterol (2008) 0.89

DNA damage mediated s and g(2) checkpoints in human embryonal carcinoma cells. Stem Cells (2009) 0.89

Multi-colour nanowire photonic crystal laser pixels. Sci Rep (2013) 0.89

Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery. Int J Nanomedicine (2012) 0.89

Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway. Int J Oncol (2011) 0.89

Creation of highly efficient solid emitter by decorating pyrene core with AIE-active tetraphenylethene peripheries. Chem Commun (Camb) (2010) 0.88

A rate-limiting role for Dickkopf-1 in bone formation and the remediation of bone loss in mouse and primate models of postmenopausal osteoporosis by an experimental therapeutic antibody. J Pharmacol Exp Ther (2011) 0.88

Effect of Mitofusin 2 on smooth muscle cells proliferation in hypoxic pulmonary hypertension. Microvasc Res (2012) 0.88

Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey. Eur J Pharm Sci (2005) 0.88

Capsular adhesion to intraocular lens in highly myopic eyes evaluated in vivo using ultralong-scan-depth optical coherence tomography. Am J Ophthalmol (2012) 0.88

Three-dimensional mapping of quantum wells in a GaN/InGaN core-shell nanowire light-emitting diode array. Nano Lett (2013) 0.87

Novel electroforming-free nanoscaffold memristor with very high uniformity, tunability, and density. Adv Mater (2014) 0.87

A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections. Chemotherapy (2010) 0.87

Synthesis and antiviral bioactivities of alpha-aminophosphonates containing alkoxyethyl moieties. Molecules (2006) 0.87

Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma. Clin Cancer Res (2008) 0.87

Localization of infection-related epitopes on the non-structural protein 3ABC of foot-and-mouth disease virus and the application of tandem epitopes. J Virol Methods (2004) 0.86

The long-lasting effects of cross-fostering on the emotional behavior in ICR mice. Behav Brain Res (2008) 0.86

Blocking glutamate-mediated signalling inhibits human melanoma growth and migration. Exp Dermatol (2012) 0.86

Guidance document for structured reporting of diuresis renography. Semin Nucl Med (2012) 0.86

Characterization of the rhesus monkey CYP3A64 enzyme: species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymes. Drug Metab Dispos (2006) 0.86

Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling. PLoS One (2013) 0.86

Induction of apoptosis and inhibition of cell growth by developmental regulator hTBX5. Biochem Biophys Res Commun (2002) 0.86

Mercury adsorption of modified mulberry twig chars in a simulated flue gas. Bioresour Technol (2013) 0.85

Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer? A result based on a hospital population of two decades as taking D2 surgery for reference. BMC Cancer (2010) 0.85